DK472887A - Imidazolylguanidinderivater, fremgangsmaade til fremstilling deraf og laegemidler, der indeholder disse forbindelser - Google Patents

Imidazolylguanidinderivater, fremgangsmaade til fremstilling deraf og laegemidler, der indeholder disse forbindelser

Info

Publication number
DK472887A
DK472887A DK472887A DK472887A DK472887A DK 472887 A DK472887 A DK 472887A DK 472887 A DK472887 A DK 472887A DK 472887 A DK472887 A DK 472887A DK 472887 A DK472887 A DK 472887A
Authority
DK
Denmark
Prior art keywords
ingrediates
imidazolylguanide
procedures
preparing
compounds
Prior art date
Application number
DK472887A
Other languages
English (en)
Other versions
DK472887D0 (da
DK165982B (da
DK165982C (da
Inventor
Armin Buschauer
Helmut Schickaneder
Peter Moersdorf
Walter Schunack
Gert Baumann
Kurt-Henning Ahrens
Original Assignee
Heumann Pharma Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heumann Pharma Gmbh & Co filed Critical Heumann Pharma Gmbh & Co
Publication of DK472887D0 publication Critical patent/DK472887D0/da
Publication of DK472887A publication Critical patent/DK472887A/da
Publication of DK165982B publication Critical patent/DK165982B/da
Application granted granted Critical
Publication of DK165982C publication Critical patent/DK165982C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK472887A 1986-09-15 1987-09-10 Imidazolylguanidinderivater og laegemidler, der indeholder disse forbindelser DK165982C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863631334 DE3631334A1 (de) 1986-09-15 1986-09-15 Neue imidazolylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3631334 1986-09-15

Publications (4)

Publication Number Publication Date
DK472887D0 DK472887D0 (da) 1987-09-10
DK472887A true DK472887A (da) 1988-03-16
DK165982B DK165982B (da) 1993-02-22
DK165982C DK165982C (da) 1993-07-26

Family

ID=6309606

Family Applications (1)

Application Number Title Priority Date Filing Date
DK472887A DK165982C (da) 1986-09-15 1987-09-10 Imidazolylguanidinderivater og laegemidler, der indeholder disse forbindelser

Country Status (17)

Country Link
US (1) US4912119A (da)
EP (1) EP0262448B1 (da)
JP (1) JPS6383072A (da)
KR (1) KR950010326B1 (da)
AT (1) ATE70533T1 (da)
AU (1) AU606882B2 (da)
CA (1) CA1249829A (da)
DE (2) DE3631334A1 (da)
DK (1) DK165982C (da)
ES (1) ES2040720T3 (da)
GR (1) GR3003388T3 (da)
HU (1) HU212302B (da)
IE (1) IE59278B1 (da)
IL (1) IL83804A (da)
NZ (1) NZ221611A (da)
PT (1) PT85697B (da)
ZA (1) ZA876163B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199845B1 (de) * 1985-04-02 1990-08-01 HEUMANN PHARMA GMBH & CO Imidazolylalkylguanidinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3726381A1 (de) * 1987-08-07 1989-02-16 Heumann Pharma Gmbh & Co Guanidincarbonsaeureester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3814057A1 (de) * 1988-04-26 1989-11-09 Heumann Pharma Gmbh & Co 6-oxo-pyridazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
ES2058651T3 (es) * 1990-03-30 1994-11-01 Heumann Pharma Gmbh & Co Uso derivados de guanidina para la fabricacion de un medicamento con actividad antagonista de npy.
JPH06505265A (ja) * 1991-02-27 1994-06-16 シード・キャピタル・インベストメント・(エス・シー・アイ)・ベスローテン・フェンノートシャップ ヒスタミンh↓3受容体に対する作動的または拮抗的活性を有するイミダゾール誘導体
NL9100365A (nl) * 1991-02-27 1992-09-16 Seed Capital Investments Imidazoolderivaten met agonistische of antagonistische activiteit op de histamine h3-receptor.
EP0526395A1 (de) * 1991-07-22 1993-02-03 Zyma SA Arylalkylaminderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
FR2686084B1 (fr) * 1992-01-10 1995-12-22 Bioprojet Soc Civ Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
USRE37303E1 (en) * 1992-01-10 2001-07-31 Institut National Del La Sante Et De La Recherche Medicale Imidazole compounds and their therapeutic applications
AU2764797A (en) * 1996-05-14 1997-12-05 Novo Nordisk A/S Somatostatin agonists and antagonists
US6127343A (en) * 1996-05-14 2000-10-03 Novo Nordisk A/S Somatostatin agonists and antagonists
JP2001502712A (ja) * 1996-10-31 2001-02-27 ノボ ノルディスク アクティーゼルスカブ 束縛されたソマトスタチン・アゴニスト及びアンタゴニスト
US5889016A (en) * 1997-06-26 1999-03-30 Bristol-Myers Squibb Company Dihydropyrimidone derivatives as NPY antagonists
US6177429B1 (en) 1999-06-21 2001-01-23 Bristol-Myers Squibb Company Dihydropyrazine derivatives as NPY antagonists
AU2001292723A1 (en) * 2000-09-20 2002-04-02 Schering Corporation Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
KR101892241B1 (ko) * 2015-11-06 2018-08-27 송재근 유분 분리 장치

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431589A (en) * 1973-07-13 1976-04-07 Smith Kline French Lab Ureas, thioureas and guanidines n,n-disubstituted by heterocyclo- alkylene and/or heterocycloalkylenethioalkylene groups
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
DK221081A (da) * 1980-05-31 1981-12-01 Smith Kline French Lab Fremgangsmaade til fremstilling af heterocyklylalkylanidiner mellemprodukter til anvendelse ved denne fremgangsmaade og en fremgangsmaade til fremstilling af disse mellemprodukter
JPH0660096B2 (ja) * 1983-11-04 1994-08-10 富山化学工業株式会社 アミン誘導体またはその塩を含有する抗潰瘍剤
EP0199845B1 (de) * 1985-04-02 1990-08-01 HEUMANN PHARMA GMBH & CO Imidazolylalkylguanidinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3528214A1 (de) * 1985-08-06 1987-02-12 Heumann Ludwig & Co Gmbh Arylalkylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3726381A1 (de) * 1987-08-07 1989-02-16 Heumann Pharma Gmbh & Co Guanidincarbonsaeureester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
ES2040720T3 (es) 1993-11-01
ATE70533T1 (de) 1992-01-15
DK472887D0 (da) 1987-09-10
NZ221611A (en) 1989-09-27
DK165982B (da) 1993-02-22
EP0262448B1 (de) 1991-12-18
US4912119A (en) 1990-03-27
DE3775319D1 (de) 1992-01-30
IE59278B1 (en) 1994-02-09
EP0262448A1 (de) 1988-04-06
IL83804A0 (en) 1988-02-29
PT85697B (pt) 1990-08-31
AU7767287A (en) 1988-03-17
DE3631334A1 (de) 1988-03-17
HU212302B (en) 1996-05-28
ZA876163B (en) 1988-02-23
KR950010326B1 (ko) 1995-09-14
JPS6383072A (ja) 1988-04-13
GR3003388T3 (en) 1993-02-17
IE872463L (en) 1988-03-15
IL83804A (en) 1993-02-21
PT85697A (de) 1987-10-01
AU606882B2 (en) 1991-02-21
CA1249829A (en) 1989-02-07
KR880003937A (ko) 1988-06-01
HUT56352A (en) 1991-08-28
DK165982C (da) 1993-07-26

Similar Documents

Publication Publication Date Title
DK472887A (da) Imidazolylguanidinderivater, fremgangsmaade til fremstilling deraf og laegemidler, der indeholder disse forbindelser
FI872756A0 (fi) Med laserstraolning fungerande terapeutisk anordning.
DK233586D0 (da) 5-substituerede 1,3-thiazolidon-2,4-dion-forbindelser og farmaceutiske praeparater indeholdende disse
DK122291A (da) Benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
FI874702A7 (fi) Menetelmä uusien bentsimidatsolijohdannaisten valmistamiseksi.
NO166639C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte, basiske 2-aminotetraliner.
MX162676A (es) Procedimiento para la preparacion de derivados de 2-(piridilalquensulfinii.)benzimidazoles n-substituidos
DK0639275T3 (da) Hidtil ukendte GABAa-receptorundertyper og fremgangsmåder til screening af lægemiddelforbindelser under anvendelse af imidazoquinoxaliner og pyrrolopyimidiner til binding til GABAa-receptorundertyper
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
DK0521768T3 (da) Nye triazolopyrimidin-derivater som er angiotensin II-receptor-antagonister, fremgangsmåder til deres fremstilling og farmaceutiske præparater med indhold deraf
DK204686D0 (da) Quinolylglycinamidderivater og fremgangsmaade til fremstilling deraf
ES549776A0 (es) Procedimiento para la preparacion de pirrolo-bencimidazoles
AR228011A1 (es) Procedimiento para la preparacion de derivados sustituidos de 2,5,5,8a-tetrametil-1,2,3,4,4a,5,6,7,8,8a-decahidronaftaleno-1-spiro-2'-(4',6',7'-sustituido-2',3'-dihidrobenzofurano)
ES2171663T3 (es) Nuevo procedimiento para la preparacion de nucleosidos.
AR216558A1 (es) Procedimiento de preparacion de 1,3-dihidro-3-(3',4',5'-trimetoxi-estiril)-6-metil-7-hidroxi-furo-(3,4,c)-piridina
IT1158450B (it) Procedimento per la preparazione dell'eritro-alfa-2-piperidil-2,8-bis-(trifluorometil)-4-chinolinmetanolo
NO167807C (no) Analogifremgangsmaate til fremstilling av 3',4'-dinitrogensubstituerte epipodofyllotoksinglukosidderivater.
IT8622467A0 (it) Procedimento per la sintesi di perfluoroalcadieni.
DK413188D0 (da) Benzimidazol-derivater til terapeutisk anvendelse og fremgangsmaade til fremstilling deraf
FI873606A7 (fi) Ihmisen glykoalbumiinin määrittämiseen käyttökelpoisia vasta-aineita.
IT7820912A0 (it) Procedimento per la preparazione di derivati di cefalosporina, e composti cosi' preparati.
ES8303412A1 (es) Procedimiento de obtencion de nuevas xantinas con actividad farmacologica
IT1225483B (it) Protesi ortopedica, particolarmente per la testa del femore.
DK688087A (da) Imidazolderivater, fremgangsmaade til fremstilling deraf og anvendelse deraf som antimycotiske midler
ES515068A0 (es) "procedimiento para la preparacion de n-(2-(((5-dimetilamino)-metil-2-furanil)-metil)-tio)-etil)-n'-(3,4-metilendioxibencil)-2-nitro-1,1-etendiamina".